Search Results for keywords:"labeling changes"

The Food and Drug Administration (FDA) has set January 1, 2024, as the uniform compliance date for food labeling regulations that were published between January 1, 2021, and December 31, 2022. This means any new food labeling rules released during this timeframe must be followed by the start of 2024 to reduce the economic impact of labeling changes on the food industry. The FDA states that while these regulations don't immediately introduce new costs, they allow businesses time to adjust their labeling practices. The rule also specifies that special circumstances may justify a different compliance date, which will be detailed as needed.

The Food and Drug Administration (FDA) has decided that the drug NYMALIZE (nimodipine), oral solution at a strength of 3 mg/mL, was not taken off the market for safety or effectiveness reasons. This decision enables the approval of generic versions of this drug, provided they meet other requirements. Although the 3 mg/mL version was discontinued, the FDA believes it would still be safe and effective if sold today, but suggests making some labeling changes to prevent confusion with another version that is 6 mg/mL.

The Food and Drug Administration (FDA) is setting January 1, 2028, as the compliance date for new food labeling regulations published between January 1, 2025, and December 31, 2026. This decision helps reduce the economic impact on the food industry by allowing time to adjust to the new labeling requirements. The FDA has not made any environmental impact assessments, as this action is considered non-significant in that regard. The announcement is effective immediately, but public comments can be submitted until March 3, 2025.